ApideckTape
← Embedded Finance Index 2026

Decoda Health

“Can an AI-powered vertical EMR become the payments and practice management OS for elective care clinics by embedding financial workflows directly into the clinical chart?”

HQUnited States
Total raised$4.5M
Latest roundSeed, led by Y Combinator
IndustryVertical SaaS / Healthcare
The story

Decoda Health started as a clinical hyperautomation platform for patient communications, then expanded into a full EMR (Electronic Medical Record) system specifically targeting modern elective care (aesthetics, medspa, weight loss). The company initially relied on a referral-based payments integration with no monetization angle, but accelerated its embedded payments strategy in 2024 by switching to Rainforest Pay, enabling fully branded payment collection across online, in-person, and ACH channels. The YC-backed $4.5M seed signals ambitions to become the vertical SaaS financial OS for elective healthcare providers.

Last 12 months
2024-10
2024
Product timeline
2024
Migrated to Rainforest Pay for fully embedded payments, launching a branded payments product in 12 days supporting card-present, online, Apple Pay, and ACH.· banking
The stack
1 layer disclosed in Decoda Health’s embedded-finance stack
Payments / PSP
Rainforest Pay
Accounting gap: significant

Decoda Health — frequently asked

Who is Decoda Health's payment processor?

Decoda Health processes payments through Rainforest Pay.

Where is Decoda Health headquartered?

Decoda Health is headquartered in United States.

How much funding has Decoda Health raised?

Decoda Health has raised $4.5M in total (latest round: Seed, led by Y Combinator).

Benchmark your own stack

Request an embedded finance strategy assessment

Get a read on where your own stack stands against Decoda Health and the rest of its category — what they built versus bought, which providers they use, and where the gaps in your own strategy and competitive set actually are.

  • Your category, mappedHow your stack compares to Decoda Health and the other companies in its category.
  • Build vs. buyWhere a provider relationship would close a gap faster than building it.
  • A named analyst, not a form replyA short call to scope what's actually worth assessing for you.

No newsletter, no sharing your address. We use this to reach out about the assessment and nothing else.